Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human eosinophils cultured on laminin or tissue fibronectin

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 2, 1997, Pages 208-215

  Walsh, Garry M ^a,b   Wardlaw, Andrew J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Cytokines; Dexamethasone; Eosinophil; Extracellular matrix; Fibronectin; Integrins; Laminin; Prolonged survival

Indexed keywords

DEXAMETHASONE; FIBRONECTIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LAMININ;

ALLERGIC REACTION; ALLERGY; ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; CYTOKINES; DEXAMETHASONE; EOSINOPHILS; FIBRONECTINS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; KINETICS; LAMININ; STIMULATION, CHEMICAL;

EID: 0030753007     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70226-4     Document Type: Article

References (29)

1. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in mild asthma. Am Rev Respir Dis 1988;138:62-9.
2. Bousquet J, Chanez P, Lacoste JY, Barneon G, Gavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-5.
3. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
4. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-6.
5. Bochner B, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1995;94:427-38.
6. Wardlaw AJ, Walsh GM, Symon FA. Mechanisms of eosinophil and basophil migration. Allergy 1994;49:797-807.
7. Spry CJF. The natural history of eosinophils. In: Smith H, Cook RM, editors. The immunopharmacology of eosinophils. London: Academic Press; 1993. p. 1-9.
8. Anwar ARE, Walsh GM, Cromwell O, Kay AB, Wardlaw AJ. Adhesion to fibronectin primes eosinophils via α4β1 (VLA-4). Immunology 1994;82:222-8.
9. Neeley SP, Hamann KJ, Dowling TL, McAllister KT, White SR, Leff AR. Augmentation of stimulated eosinophil degranulation by VLA-4 (CD49d)-mediated adhesion to fibronectin. Am J Respir Cell Mol Biol 1994;11:206-13.
10. 2 in response to physiologic soluble stimuli is differentially modulated by extracellular matrix components and endothelial cells. J Immunol 1991;147:613-20.
11. Kita H, Horie S, Gleich GJ. Extracellular matrix proteins attenuate activation and degranulation of stimulated eosinophils. J Immunol 1996;156:1174-81.
12. Anwar ARE, Moqbel R, Walsh GM, Kay AB, Wardlaw AJ. Adhesion to fibronectin prolongs eosinophil survival. J Exp Med 1993;177:839-43.
13. Walsh GM, Symon FS, Wardlaw AJ. Human eosinophils preferentially survive on tissue fibronectin compared with plasma fibronectin. Clin Exp Allergy 1995;25:1128-35.
14. Georas SN, McIntyre BW, Ebisawa M, Bednarczyk JL, Sterbinsky SA, Schleimer RP, et al. Expression of a functional laminin receptor (α6β1, very late activation antigen-6) on human eosinophils. Blood 1993;82:2872-9.
15. Tourkin A, Anderson T, LeRoy EC, Hoffman S. Eosinophil adhesion and maturation is modulated by laminin. Cell Adhes Commun 1993;1:161-76.
16. Schleimer RP. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 1990;141:S59-69.
17. Hansel TT, De Vries IJM, Iff T, Rihs S, Wandzilak M, Betz S, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-10.
18. Walsh GM, Symon FA, Lazarovits AI, Wardlaw AJ. Integrin α4β7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin. Immunology 1996;89:112-9.
19. Mould AP, Wheldon A, Komoriya E, Wayner EA, Yamada KM, Humphries MJ. Affinity chromatic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin and its identification as the integrin α4β1. J Biol Chem 1990;265:4020-4.
20. Kuijpers TW, Mul EPJ, Blom M, Kovach NL, Gaeta CA, Tollefson V, et al. Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration. J Exp Med 1993;178:279-84.
21. Horie S, Kita H. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony stimulating factor and platelet activating factor. J Immunol 1994;152:5457-67.
22. Kornblihtt AR, Umezawa K, Vibe-Pedersen K, Baralle F. Primary structure of human fibronectin: differential splicing may generate at least ten polypeptides from a single gene. EMBO J 1985;4:1755-9.
23. Hershberger RP, Culp LA. Cell type specific expression of alternatively-spliced human fibronectin IIICS mRNAs. Mol Cell Biol 1990;10:662-71.
24. Yamada KM. Fibronectin and other cell interactive glycoproteins. In: Hay ED, editor. Cell biology of extra-cellular matrix. New York: Plenum Press; 1991. p. 111-46.
25. Her E, Frazer J, Austen KF, Owen WF. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. J Clin Invest 1991;88:1982-7.
26. Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 1991;147:3490-5.
27. Lamas AM, Leon OG, Schleimer RP. Glucocorticoids inhibit eosinophil responses of granulocyte-macrophage colony-stimulating factor. J Immunol 1991;147:254-9.
28. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996;156:4422-8.
29. Kawabori S, Soda K, Perdue MH, Bienenstock J. The dynamics of intestinal eosinophil depletion in rats treated with dexamethasone. Lab Invest 1991;64:224-33.